# Hydroxyurea

## Hydrea 500mg

| TAH Drug Code      | [OHYD](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OHYD)                                                                                                                                                                                                                           |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of chronic myelogenous leukemia (for early treatment and palliative care). Treatment of recurrent， metastatic， or inoperable ovarian cancer. Used in combination with radiation therapy for local control of primary head and neck squamous cell carcinoma， excluding lip cancer. |
| Dosing             | [Solid tumor] Intermittent therapy: 80 mg/kg once every 3 days; Continuous therapy: 20-30 mg/kg once daily [Squamous cell carcinoma of head and neck or cervical cancer， in combination with radiation therapy] 80 mg/kg once every 3 days [Chronic myeloid leukemia] 20-30 mg/kg once daily  |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                       |
| Contraindications  | Hypersensitivity. Bone marrow depression eg leukopenia， thrombocytopenia or severe anemia. Pregnancy & lactation.                                                                                                                                                                             |
| Adverse Effects    | Bone-marrow suppression; rarely， GI disorders， skin rash， headache， disorientation， pulmonary edema， dysuria， renal tubular function impairment.                                                                                                                                        |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                   |
| More Info          | [UpToDate](https://www.uptodate.com/contents/hydroxyurea-drug-information)                                                                                                                                                                                                                     |

